Table of Contents
Share At:
Listen Article:
0:00 /
0:00
Tolvaptan Tablet During Pregnancy
Table of Contents
During pregnancy, tolvaptan tablet has been used to prevent certain birth defects. It should be used only under the supervision of a doctor. It is also not recommended to take the medication in large amounts. The recommended dosage is one tablet per day.
What is the Dosage of Tolvaptan Tablet?
Typically, tolvaptan is taken by mouth, once or twice a day. It is used to treat hyponatremia (low blood sodium levels), which occurs when there is not enough water in the body. Tolvaptan blocks the receptor on the kidneys that are responsible for absorbing water, which allows the kidneys to excrete more water as urine. It is approved for treating hyponatremia in adult patients in Europe and in the US.
Tolvaptan is a selective antagonist of the vasopressin V2 receptor, which prevents aquaporins from lining the walls of the kidneys. This causes the kidneys to clear water, which slows down the progression of renal dysfunction. The drug is available in a tablet form.
The usual starting dose of tolvaptan is 15 mg, taken by mouth once a day. The drug can be increased to a dose of 60 mg per day, depending on the patient’s response and side effects.
Tolvaptan is also available in a tablet form, which can be split into two doses. Tolvaptan is a potent vasopressin V2 receptor antagonist, and is used to treat hyponatremia, which is caused by a variety of conditions.
How does Tolvaptan Tablet Work?
Tolvaptan Tablet includes plasma concentrations, the area under the curve (AUC), and changes in the pharmacodynamic end points. These parameters are determined by high-performance liquid chromatography with tandem mass spectrometry.
Plasma concentrations of tolvaptan were measured after ad libitum water intake and ad libitum water withdrawal for 2 h. Plasma samples were then dialyzed at 37degC for 7 h with a rapid equilibrium dialysis 96-well system. Then, aliquots were analyzed using high-performance liquid chromatography with tandem Mass spectrometry.
The pharmacodynamic end points were summarized using descriptive statistics by time point. Results showed that tolvaptan reduced the mean CrCL (creatinine clearance) by four to seven percent in patients with renal impairment. This is comparable to the effects seen in patients with autosomal dominant polycystic kidney disease. However, the reductions were not statistically significant.
Plasma concentrations of tolvaptan showed a rapid onset and were reached at a maximum level about 2 h after dosing. Plasma concentrations decreased in an exponential fashion. This may be explained by a greater time needed to excrete water.
Tolvaptan Tablet Prevalence in Urban Areas
Despite the fact that tolvaptan is a relatively new drug in Japan, the prevalence of the medicine is surprisingly high. The number of tablets prescribed for a given population is not exactly the same across prefectures. The prevalence of tolvaptan in the city may be higher than in the suburbs. Nevertheless, it is still an enigma as to why the number of tolvaptan prescriptions has not increased in recent years.
Although the prevalence of tolvaptan tablets in the city may not have increased in the last few years, the number of prescribed tablets for a given population has definitely increased. Compared with rural areas, urban areas tend to adopt new medicines and treatments first. This study suggests that tolvaptan is a promising addition to the armamentarium.
Tolvaptan is a vasopressin receptor 2 antagonist. It has a number of interesting properties including diuretic actions. It has also been demonstrated that tolvaptan can be effective in treating hyponatremia. In addition, tolvaptan is the first drug approved in Japan for treating ADPKD.
The Bottom Line
Tolvaptan is a selective vasopressin V2 receptor antagonist. It is used to treat polycystic kidney disease, which is characterized by the formation of cysts. It also inhibits cell proliferation. It can cause severe side effects, so it is best to avoid taking it.
If you are planning to become pregnant, you should tell your doctor about your medications. He or she will be able to tell you about medications that are safe to take during pregnancy and will also give you information about safe alternatives. You should also use adequate contraceptive measures while you are taking the medicine.
